World

Lonza and Engitix Partner to Advance Next-Generation ECM-Targeted ADCs

Lonza grants Engitix target-specific license for GlycoConnect®, HydraSpace® and SYNtecan E™ linker-payload technologies for ADC de...

 July 22, 2026 | News

Lundbeck Completes Patient Randomisation in Phase III Bexicaserin Trial for Rare Epilepsies

DEEp OCEAN is a global trial designed to evaluate the investigational molecule bexicaserin for the treatment of seizures associated with DEEs, a diverse ...

 July 22, 2026 | News

Vector Partners with Caresyntax to Build Real-World Evidence Programme for Opioid-Sparing Surgical Platform

Caresyntax will design and operate a multi-phase real-world evidence program for Vector, culminating in a prospective comparative reg...

 July 21, 2026 | News

Samsung Biologics Launches CHF 1.46B All-Cash Bid to Acquire PolyPeptide

Samsung Biologics to launch an all-cash public tender offer for 100% of PolyPeptide's fully diluted share capital (excluding therefrom any treasury share...

 July 21, 2026 | News

Australia and Taiwan Build a Faster Clinical Bridge for Global Biotech Development

  As biotechnology companies face mounting pressure to move promising science into human studies faster, the relationship between Australia and Taiwa...

 July 20, 2026 | News

From Capacity to Capability: The New Race to Lead ASEAN Biomanufacturing

  ASEAN is entering a new phase of biopharmaceutical manufacturing, where simply building more capacity will no longer guarantee competitiveness. As ...

 July 17, 2026 | Expert Insight

Septa Pharmaceuticals Acquires CeeNU from Bristol Myers Squibb Canada

 Septa Pharmaceuticals Inc., a rapidly growing leader in the Canadian healthcare sector, is proud to announce the successful acquisition of CeeNU...

 July 17, 2026 | News

Metabolon Expands Microbiome Panel to Screen Over 800 Metabolites

Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health,...

 July 17, 2026 | News

Evonik and evitria Simplify CHO-Based Protein Production with Ready-to-Use Expression Kit

New ready-to-use protein expression kit now available eviCHO Expression Kit simplifies transient protein expression workflows and enables faster, ...

 July 17, 2026 | News

Insilico Medicine, Bora Pharmaceuticals Forge $2.5B Alliance to Build AI-Driven Drug Innovation Model

Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generat...

 July 16, 2026 | News

Q32 Bio Reports Positive Phase 2a Results for Bempikibart in Severe Alopecia Areata, Plans Pivotal Programme

-- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline o...

 July 15, 2026 | News

BioArctic and Eisai Secure FDA Approval for At-Home Leqembi Injection to Treat Early Alzheimer's Disease

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced that the US Food and Drug Administration (FDA) has approved a supplement...

 July 15, 2026 | News

Mindbeam AI Unveils Generative AI Breakthrough for Safer Next-Generation Pain Therapies

Mindbeam AI, the company focused on next-generation AI infrastructure,  announced a new research breakthrough showing how generative AI can accelerate...

 July 13, 2026 | News

ACHP Launches Patient Advisory Council to Put Chronic Disease Voices at the Heart of Research

The Alliance of Community Health Plans (ACHP) is amplifying patients' voices on chronic disease research via its newly launched Patient Advisory Council. T...

 July 13, 2026 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close